Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE.

The article addresses a correction regarding the name of Dr. Enrico Matteo Garanzini, which was inaccurately presented in a previously published article. The correction clarifies that his name should be listed as Garanzini Enrico Matteo. This erratum serves to ensure the accuracy of authorship in th...

Full description

Bibliographic Details

Published in:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 52; no. 13; pp. 5208 - 5209
Main Authors:	Maccauro, Marco, Cuomo, Mariarosaria, Bauckneht, Matteo, Bagnalasta, Matteo, Mazzaglia, Stefania, Scalorbi, Federica, Argiroffi, Giovanni, Kirienko, Margarita, Lorenzoni, Alice, Aliberti, Gianluca, Pusceddu, Sara, Giuseppina, Calareso, Garanzini, Enrico Matteo, Seregni, Ettore, Chiesa, Carlo
Format:	Journal Article
Published:	Springer Nature Nov2025
Online Access:	View this record in EBSCOhost